Traws Pharma Income Statement (2012-2025) | TRAW

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	2.73M
Operating items
Research & Development (Quarter)	1.94M	1.85M	1.76M	1.75M	2.00M	2.04M	3.59M	3.77M	4.08M	2.46M	2.46M	2.43M	1.91M	3.96M	5.11M	1.86M	2.51M	2.29M	2.31M	5.04M
Selling, General & Administrative (Quarter)	2.22M	2.85M	2.28M	2.07M	2.19M	2.14M	2.10M	2.02M	2.11M	2.21M	2.69M	2.08M	3.36M	1.98M	3.48M	3.48M	2.75M	1.69M	1.74M	2.33M
Restructuring Costs (Quarter)													2.58M	0.85M	0.97M	0.97M	1.85M	0.55M	0.50M	0.89M
Other Operating Expenses (Quarter)													-2.58M	116.61M	-0.97M	-0.97M	-1.85M	-0.55M	-0.50M	-0.89M
Operating Expenses (Quarter)	4.15M	4.70M	4.05M	3.82M	4.19M	4.18M	5.70M	5.79M	6.19M	4.67M	5.15M	4.52M	5.27M	123.41M	8.59M	5.33M	5.26M	3.98M	4.05M	7.37M
Operating Income (Quarter)	-4.10M	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M
EBIT (Quarter)	-4.10M	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M
Non-operating items
Other Non Operating Income (Quarter)	0.02M	-0.01M	0.01M	-0.00M	0.01M	0.10M	0.24M	0.31M	0.36M	0.36M	0.35M	0.28M	0.23M	0.20M	0.06M	-0.21M	0.18M	0.19M	0.10M	0.01M
Non Operating Income (Quarter)	0.02M	-0.01M	0.01M	-0.00M	0.01M	0.10M	0.24M	0.31M	0.36M	0.36M	0.35M	0.28M	0.23M	0.20M	0.06M	-0.21M	0.18M	0.19M	0.10M	0.01M
Net income details
EBT (Quarter)	-4.10M	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-4.71M	-4.23M	-3.45M	-3.76M	-4.12M	-4.02M	-5.40M	-5.42M	-5.78M	-4.25M	-4.74M	-4.18M	-4.98M	-123.14M	-8.47M	-29.92M	21.49M	-0.92M	-3.96M	-7.44M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-4.10M	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M
Consolidated Net Income (Quarter)	-4.10M	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M
Income towards Parent Company (Quarter)	-4.10M	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M
Preferred Dividend Payments (Quarter)														-102.37M	-7.04M	-8.50M	6.41M	-0.29M	-0.93M	-2.04M
Net Income towards Common Stockholders (Quarter)	-4.10M	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-4.98M	-20.77M	-1.43M	-21.42M	15.08M	-0.62M	-3.04M	-5.40M
Additional items
EPS (Basic) (Quarter)	-0.32	-0.27	-0.22	-0.16	-0.20	-0.19	-0.26	-0.26	-0.28	-0.20	-5.64	-4.98	-5.92	-20.52	-1.49	-3.35	2.17	-0.11	-0.34	-0.73
EPS (Weighted Average and Diluted) (Quarter)	-0.32	-0.27	-0.22	-0.16	-0.20	-0.19	-0.26	-0.26	-0.28	-0.20	-5.64	-4.98	-5.92	-20.52	-1.49	-3.35	2.09	-0.11	-0.34	-0.71
Shares Outstanding (Weighted Average) (Quarter)	7.81M	0.52M	0.51M	16.83M	0.50M	20.90M	0.50M	20.91M	0.35M	0.35M	0.35M	0.84M	0.84M	1.01M	0.96M	1.55M	6.97M	5.82M	8.82M	8.23M
Shares Outstanding (Diluted Average) (Quarter)	14.62M	15.78M	15.46M	16.83M	20.90M	20.90M	20.92M	20.91M	20.96M	20.97M	0.84M	0.84M	0.84M	0.93M	0.96M	1.55M	7.22M	5.82M	8.82M	8.38M
EBITDA (Quarter)	-4.10M	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M
Interest Expenses (Quarter)
Tax Rate (Quarter)

Research Tools

Traws Pharma Income Statement (2012-2025) | TRAW

Create an account

Sign In

Reset Password